Loading market dashboard
Black Diamond Therapeutics, Inc.
BDTXHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Black Diamond Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $84.50M | $84.50M - $84.50M | $72.48M | -$0.621 | 7 |
| Dec 2029 | $13.33M | $13.33M - $13.33M | $11.43M | -$1.257 | 7 |
| Dec 2028 | $11.59M | $11.59M - $11.59M | $9.94M | -$0.999 | 8 |
| Dec 2027 | $2.85M | $2.85M - $2.85M | $2.44M | -$1.005 | 8 |
| Dec 2026 | $7.14M | $7.14M - $7.14M | $6.13M | -$0.647 | 6 |
| Dec 2025 | $70.00M | $70.00M - $70.00M | $60.04M | $0.447 | 7 |
| Dec 2024 | $70.00M | $70.00M - $70.00M | $60.04M | -$1.299 | 4 |